Stefanie Herkt

434 total citations
11 papers, 232 citations indexed

About

Stefanie Herkt is a scholar working on Molecular Biology, Hematology and Physiology. According to data from OpenAlex, Stefanie Herkt has authored 11 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Physiology. Recurrent topics in Stefanie Herkt's work include Acute Myeloid Leukemia Research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Stefanie Herkt is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Stefanie Herkt collaborates with scholars based in Germany, United States and Hungary. Stefanie Herkt's co-authors include Thomas Oellerich, Halvard Bönig, Olga N. Kuvardina, Jörn Lausen, Julia Herglotz, Stephan Kolodziej, Erhard Seifried, Ashok Kumar, Hubert Serve and Joachim Koch and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Stefanie Herkt

11 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefanie Herkt Germany	7	135	94	40	38	38	11	232
Desmond Wai Loon Chin Singapore	6	157 1.2×	106 1.1×	18 0.5×	41 1.1×	33 0.9×	12	235
Antonella Santoro United Kingdom	6	195 1.4×	116 1.2×	38 0.9×	38 1.0×	26 0.7×	10	290
Monika Gothwal Germany	6	163 1.2×	62 0.7×	23 0.6×	61 1.6×	53 1.4×	8	244
Nirmalee Abayasekara United States	5	268 2.0×	107 1.1×	27 0.7×	54 1.4×	68 1.8×	5	368
Moonjung Jung United States	8	89 0.7×	55 0.6×	25 0.6×	39 1.0×	13 0.3×	17	181
Himalee S. Sabnis United States	8	123 0.9×	85 0.9×	47 1.2×	14 0.4×	30 0.8×	20	234
Tassja J. Spindler United States	6	96 0.7×	40 0.4×	48 1.2×	21 0.6×	52 1.4×	10	192
Justine Clark United States	8	138 1.0×	153 1.6×	48 1.2×	59 1.6×	46 1.2×	9	248
Bert van der Reijden Netherlands	7	201 1.5×	182 1.9×	33 0.8×	21 0.6×	71 1.9×	13	314
Bilyana Stoilova United Kingdom	7	177 1.3×	179 1.9×	29 0.7×	44 1.2×	28 0.7×	10	287

Countries citing papers authored by Stefanie Herkt

Since Specialization

Citations

This map shows the geographic impact of Stefanie Herkt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Herkt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Herkt more than expected).

Fields of papers citing papers by Stefanie Herkt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Herkt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Herkt. The network helps show where Stefanie Herkt may publish in the future.

Co-authorship network of co-authors of Stefanie Herkt

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Herkt. A scholar is included among the top collaborators of Stefanie Herkt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Herkt. Stefanie Herkt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Manns, Patricia J., Stefanie Herkt, Sang‐Cheol Lee, et al.. (2024). REAL WORLD PRODUCT QUALITY DATA OF CAR-ENGINEERED NK CELLS FOR INTRACRANIAL INJECTION IN PATIENTS WITH RECURRENT HER2-POSITIVE GLIOBLASTOMA FROM THE ONGOING CAR2BRAIN CLINICAL TRIAL. Cytotherapy. 26(6). S9–S10. 1 indexed citations

Burger, Michael C., Marie-Thérèse Forster, A Romański, et al.. (2022). A phase I first-in-human trial with local application of CAR-NK cells targeting HER2 in patients with recurrent glioblastoma (CAR2BRAIN): results of the dose-escalation cohort. S3–S3. 2 indexed citations

Schneider, Lucas, Stefanie Herkt, Olga N. Kuvardina, et al.. (2021). PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1. Oncogenesis. 10(5). 42–42. 21 indexed citations

Herkt, Stefanie, Heike Kunze‐Schumacher, Lucas Schneider, et al.. (2020). The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis. Scientific Reports. 10(1). 21438–21438. 11 indexed citations

Godavarthy, Parimala Sonika, Rahul Kumar, Stefanie Herkt, et al.. (2019). The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis. Haematologica. 105(1). 136–147. 49 indexed citations

Herkt, Stefanie, Olga N. Kuvardina, Julia Herglotz, et al.. (2017). Protein arginine methyltransferase 6 controls erythroid gene expression and differentiation of human CD34⁺ progenitor cells. Haematologica. 103(1). 18–29. 14 indexed citations

Kuvardina, Olga N., Stefanie Herkt, Lucas Schneider, et al.. (2017). Hematopoietic transcription factors and differential cofactor binding regulatePRKACBisoform expression. Oncotarget. 8(42). 71685–71698. 3 indexed citations

Kolodziej, Stephan, Olga N. Kuvardina, Julia Herglotz, et al.. (2016). MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO. PLoS Genetics. 12(3). e1005946–e1005946. 21 indexed citations

Kuvardina, Olga N., Julia Herglotz, Stephan Kolodziej, et al.. (2015). RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation. Blood. 125(23). 3570–3579. 82 indexed citations

10.

Herkt, Stefanie, Antje Richter, Nefertiti El-Nikhely, et al.. (2014). ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth. Scientific Reports. 4(1). 6899–6899. 24 indexed citations

11.

Herkt, Stefanie, et al.. (2013). The T-Cell Oncogene Tal2 Is a Target of PU.1 and Upregulated during Osteoclastogenesis. PLoS ONE. 8(9). e76637–e76637. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact